feed,title,long_url,short_url
Benzinga,Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook,https://www.benzinga.com/node/19096208,https://j.mp/38yCzbO
Benzinga,Orchard Therapeutics Announces 2021 Corporate Priorities Supporting the Build-out of its Commercial Business in Hematopoietic Stem Cell (HSC) Gene Therapy and Expansion of its Clinical Applications,https://www.benzinga.com/node/19096207,https://j.mp/39poZGE
Benzinga,Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021,https://www.benzinga.com/pressreleases/21/01/g19096204/passage-bio-announces-plan-to-deliver-on-multiple-meaningful-catalysts-in-2021,https://j.mp/3bupK4a
Benzinga,Sotera Health Announces Preliminary Fourth-Quarter and Full-Year 2020 Revenue,https://www.benzinga.com/pressreleases/21/01/g19096202/sotera-health-announces-preliminary-fourth-quarter-and-full-year-2020-revenue,https://j.mp/3smdysf
Benzinga,Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEXÂ®2-73 (blarcamesine) in People with Parkinson's Disease,https://www.benzinga.com/pressreleases/21/01/g19096201/anavex-life-sciences-receives-michael-j-fox-foundation-grant-for-clinical-study-of-anavex-2-73-bla,https://j.mp/3ouEDXE
Benzinga,Teladoc Health and Dexcom Bring CGM Technology and Personalized Insights to People with Type 2 Diabetes at No Cost,https://www.benzinga.com/pressreleases/21/01/g19096200/teladoc-health-and-dexcom-bring-cgm-technology-and-personalized-insights-to-people-with-type-2-dia,https://j.mp/3oASxrc
Benzinga,Travere Therapeutics Provides Corporate Update and 2021 Outlook,https://www.benzinga.com/pressreleases/21/01/g19096199/travere-therapeutics-provides-corporate-update-and-2021-outlook,https://j.mp/3oA2Ls2
Benzinga,Skylight Health To Host Institutional Investor Meetings At The 39th Annual J.P. Morgan Healthcare Conference,https://www.benzinga.com/pressreleases/21/01/g19096198/skylight-health-to-host-institutional-investor-meetings-at-the-39th-annual-j-p-morgan-healthcare-c,https://j.mp/3q6PKqa
Benzinga,"Amydis Announces Successful Completion of Pre-IND Meeting with the FDA for the Development of AMDX-2011P, a First-in-Class Retinal Tracer for the Diagnosis of Amyloid Angiopathy",https://www.benzinga.com/pressreleases/21/01/g19096197/amydis-announces-successful-completion-of-pre-ind-meeting-with-the-fda-for-the-development-of-amdx,https://j.mp/2XvFQSM
Benzinga,Local Man Creates Handy Double-Sided Mask Clip,https://www.benzinga.com/pressreleases/21/01/g19096196/local-man-creates-handy-double-sided-mask-clip,https://j.mp/3i0uS13
Benzinga,EU5 Cranio Maxillofacial Fixation (CMF) Procedures Outlook to 2025 - Cranio Maxillofacial Fixation (CMF) Procedures,https://www.benzinga.com/pressreleases/21/01/g19096192/eu5-cranio-maxillofacial-fixation-cmf-procedures-outlook-to-2025-cranio-maxillofacial-fixation-cmf,https://j.mp/2MKmVBo
Benzinga,Bristol Myers Squibb Announces $2 Billion Incremental Share Repurchase Authorization,https://www.benzinga.com/pressreleases/21/01/b19096193/bristol-myers-squibb-announces-2-billion-incremental-share-repurchase-authorization,https://j.mp/2LoMhVh
